Health risks drive Canada's peptide crackdown In Canada, injectable peptides are classified as prescription drugs and must receive authorisation from Health Canada before they can be sold
Aroda, M.D., from Brigham and Women's Hospital in Boston, and colleagues randomly assigned adults with type 2 diabetes inadequately controlled with diet and exercise to receive once-weekly subcutaneous cagrilintide 2.4 mg plus semaglutide 2.4 mg, cagrilintide 1.0 mg plus semaglutide 1.0 mg, or placebo for 40 weeks (62, 63, and 64 participants, respectively)
Evidence has emerged to indicate a correlation between ferroptosis and the risk factors for CECs damage
The research is young but growing rapidly, and BPC-157 stands out as a compound with profound regenerative potential
The GIP receptor component may enhance insulin sensitivity and support fat metabolism
Adriaenssens AE, Biggs EK, Darwish T et al (2019) Glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus regulate food intake